Impact of coagulation in the development of thromboembolic events in patients with spinal cord injury

Carregando...
Imagem de Miniatura
Citações na Scopus
9
Tipo de produção
article
Data de publicação
2014
Título da Revista
ISSN da Revista
Título do Volume
Editora
NATURE PUBLISHING GROUP
Citação
SPINAL CORD, v.52, n.4, p.327-332, 2014
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Study design: Although the knowledge described about risk factors and venous thromboembolism (VT) in the general population, the impact of these factors in the development of thromboembolic events in patients with spinal injury (SI) caused by spinal cord injury (SCI) is poorly understood. Objective: Evaluate the impact of risk factors in the development of thromboembolic events in patients with SCI. Setting: Brazil, Sao Paulo. Methods: Observational, prospective and cross-study. Eligible patients (n = 100) had SI by SCI, > 18 years. The degree of motor and sensory lesion was evaluated based on American Spinal Injury Association (ASIA) Impairment Scale (AIS). Blood samples were collected for coagulation exams, hemogram, laboratory and biochemical analyses. Ultrasonography analyzes were performed from deep and superficial venous systems of lower limbs. Quantitative real-time PCR experiments were performed in order to investigate mutations in the prothrombin (G20210A) and Leiden factor V (G1691A) genes. Results: The main finding of this study was the higher occurrence of deep venous thrombosis (DVT) in patients with Leiden factor V and hyperhomocysteinemia. There was no association between SI for DVT, VT and thrombophilia. Also, there was no relation between lupus anticoagulant and anti-cardiolipin. Conclusion: There is an important difference in the incidence of DVT in patients with SI by acute and chronic SCI. Therefore, the conduct of the investigation for thrombophilia should be based on clinical factors, risk factors for DVT and family history of thrombosis.
Palavras-chave
thromboembolism, spinal cord injury, Leiden factor V, hyperhomocysteinemia
Referências
  1. American Spinal Injury Association, INT STAND NEUR CLASS
  2. American Spinal Injury Association/International Medical Society of Paraplegia (ASIA/IMSOP), 1992, INT STAND NEUR FUNCT
  3. BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0
  4. Boudaoud L, 1997, SPINAL CORD, V35, P151, DOI 10.1038/sj.sc.3100373
  5. Chung SB, 2011, J TRAUMA, V71, P867, DOI 10.1097/TA.0b013e31822dd3be
  6. Ersoz G, 1999, SPINAL CORD, V37, P644, DOI 10.1038/sj.sc.3100903
  7. Franco RF, 1999, BRIT J HAEMATOL, V104, P50, DOI 10.1046/j.1365-2141.1999.01149.x
  8. GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401
  9. Gren D, 2003, ARCH J PHYS MED REHA, V82, P950
  10. Guyatt GH, 2012, CHEST S, V141
  11. Iversen PO, 2002, BRIT J HAEMATOL, V119, P1011, DOI 10.1046/j.1365-2141.2002.03953.x
  12. YAO JST, 1992, CHEST, V102, pS645, DOI 10.1378/chest.102.6_Supplement.645S
  13. KIM SW, 1994, ARCH PHYS MED REHAB, V75, P965
  14. MERLI GJ, 1993, ARCH PHYS MED REHAB, V74, P1199
  15. Miranda AR, 2000, HEMATOL ONCOL CLIN N, V14, P401, DOI 10.1016/S0889-8588(05)70141-6
  16. MYLLYNEN P, 1985, J TRAUMA, V25, P541, DOI 10.1097/00005373-198506000-00013
  17. Paffrath T, 2010, INJURY, V41, P97, DOI 10.1016/j.injury.2009.06.010
  18. WARING WP, 1991, PARAPLEGIA, V29, P8
  19. Zoiler B, 1999, HAEMATOLOGICA, V84, P59